TrialVaccine2022

A phase 2 randomized controlled dose-ranging trial of recombinant pertussis booster vaccines containing genetically inactivated pertussis toxin in women of childbearing age.

Kulkanya Chokephaibulkit et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.